Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 21, 2020 - Issue 7
Submit an article Journal homepage
2,951
Views
7
CrossRef citations to date
0
Altmetric
Editorial

What are the challenges with the pharmacological management of epilepsy in patients with Attention Deficit Hyperactivity Disorder (ADHD)?

Sara Matricardia Department of Child Neuropsychiatry, Children’s Hospital “G. Salesi”, Ospedali Riuniti Ancona, Ancona, ItalyView further author information
,
Giovanni Farellob Pediatric Clinic, Department of Life, Health and Environmental Sciences, University of L’Aquila, L’Aquila, ItalyView further author information
,
Francesca Felicia Opertoc Child and Adolescent Neuropsychiatry, Department of Medicine, Surgery, and Odontoiatry, University of Salerno, Salerno, ItalyView further author information
,
Giangennaro Coppolac Child and Adolescent Neuropsychiatry, Department of Medicine, Surgery, and Odontoiatry, University of Salerno, Salerno, ItalyView further author information
&
Alberto Verrottid Department of Pediatrics, University of L’Aquila, L’Aquila, ItalyCorrespondence[email protected]
View further author information
Pages 737-739 | Received 29 Nov 2019, Accepted 17 Feb 2020, Published online: 20 Feb 2020

References

  • Camfield P, Camfield C. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord. 2015;17:117–123.
  • Parisi P, Moavero R, Verrotti A, et al. Attention deficit hyperactivity disorder in children with epilepsy. Brain Dev. 2010;32:10–16.
  • Karalok ZS, Öztürk Z, Gunes A. Cortical thinning in benign epilepsy with centrotemporal spikes (BECTS) with or without attention-deficit/hyperactivity (ADHD). J Clin Neurosci. 2019;68:123–127.
  • Sherman EM, Slick DJ, Connolly MB, et al. ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy. Epilepsia. 2007;48:1083–1091.
  • Medel-Matus JS, Shin D, Sankar R, et al. Galanin contributes to monoamonergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy. Exp Neurol. 2017;289:64–72.
  • Verrotti A, Moavero R, Panzarino G, et al. The challenge of pharmacotherapy in children and adolescents with epilepsy-ADHD comorbidity. Clin Drug Investig. 2018;38:1–8.
  • The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry. 1999;56:1073–1086.
  • NICE guidelines. September 2008. [cited Sept 2017]. Available from: https://www.nice.org.uk/guidance/CG72/chapter/Recommendations#treatment-forchildren-and-young-people
  • Gucuyener K, Erdemoglu AK, Senol S, et al. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities. J Child Neurol. 2003;18:109–112.
  • Radziuk AL, Kieling RR, Santos K, et al. Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult-to-treat epilepsies. Epilepsy Behav. 2015;46:215–220.
  • Auvin S1, Wirrell E2, Donald KA, et al. Systematic review of the screening, diagnosis, and management of ADHD in children with epilepsy. Consensus paper of the Task Force on Comorbidities of the ILAE Pediatric Commission. Epilepsia. 2018;59:1867–1880.
  • McAfee AT, Landon J, Jones M, et al. A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications. Pharmacoepidemiol Drug Saf. 2013;22:386–393.
  • Masur D, Shinnar S, Cnaan A, et al. Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology. 2013;81:1572–1580.
  • Afzal KI, Anam S, Hunter SJ. The effects of antiepileptic drugs on pediatric cognition, mood, and behavior. J Pediatr Epilepsy. 2017;6:3–18.
  • Zaccara G, Perucca E. Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord. 2014;16:409–431.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.